GRANTS, PUBLICATIONS & PATENTS

GRANTS, PUBLICATIONS & PATENTS

Extramural grants:

  • Faculty from JIPMER have received several grants in the past year from ICMR, DBT, DHR funding and many international collaborations as Principal investigators and Co-investigators.
  • Currently around 178 projects are on-going with a total sanctioned amount of 86.18 crores funded by different funding agencies.
  • Of these, 44 new projects have been mapped in SFACTs till 14/02/2024.
  • Total funds received from the various funding agencies during the current financial Year 2023-24 (covering the period from 01.04.2023 to 14.02.2024) and mapped in SFACTS is Rs 22.19 crores.
Funding source Projects Amount (INR)

ICMR

74

236685176

DBT, DST

12

108020818

NIH and other US grants

9

112827266

Ministry of Health & programs

6

190563290

DHR

5

65206920

SERB

5

15551528

JAANA

4

2997969

BIRAC

3

38693580

WHO

2

3129382

Other agencies

58

88172424

 Total

178

86,18,48,352

Intramural grants:

  • The institute has sanctioned intramural grant of about 1.98 crores to faculty and junior researchers for carrying out research projects in their area of interest in 2023-24.

Student group

Upper limit

No. of projects

Funds

Faculty

 

5

500880

PhD

Rs. 7.5 lakh

4

1053786

DM/MCh

Rs. 1.5 lakh

18

2285145

MD/MS

Rs. 1.5 lakh

106

14632733

MSc, MPH, etc

Rs. 0.5 lakh

62

1350298

TOTAL

 

195

1,98,22,842

 

  • Two new grants have been introduced this year - Competitive Intramural Research Grants for Faculty and Early-Career Intramural Research Grants for younger Faculty support high-quality, innovative research ideas.
  • Undergraduate students conduct research under the supervision of faculty members. A sizeable number of undergraduate students get research studentship grants from ICMR annually – 36 students for the year 2022-23.
  • Around 26 students received awards under the Golden Jubilee - Short Term Research Award for Undergraduate Students (GJ-STRAUS) for the year 2023-24.

Publications by JIPMER Faculty:

The faculty of JIPMER publish a substantial number of research papers every year. The number of publications is one of the metrics by which research can be quantified and the increase in the number indicates the positive trend. Nearly 1054 scientific publications were brought out by the faculty during the year 2022-23 (figures for the year 2023-24 under compilation).

Innovation And Development Projects:

JIPMER has filed 12 patent applications at Indian Patent Office, Chennai, of which six have been granted and the rest are under examination.  Presently, the firm Altacit Global, Chennai, has been deployed as a consultant for filing patent applications and following up on the processes therein for the grant of a patent.  

Sl. No

Patent Application

Patent number & Date of patent

Name of the Inventor

Project Title

1

201741005888

505713;

20.02.2017

Dr. Dinesh Kumar S

Castroviejo extender

2

201741012916

511290;

11.04.2017

Dr. Arun Alexander

Hinged eyeless needle for Trans-cartilaginous sutures

3

201741016702

470570;

12.05.2017

Dr. Shashi Ahuja

Novel use of Optical Coherence Tomography

4

201741027767

426995;

04.08.2017

Dr. Barath Jagadisan

Spiral Interlocking Threaded (SILT) internal bolster

5

201741035126

482426;

04.10.2017

Dr. Lenin Babu

Linepub device to identify the integrity of inner tube of Bain''s circuit

6

202041049056

431589;

10.11.2020

Dr. Sunil K. Narayan

Biodegradable nerve conduit and method thereof

 

Notable Projects

  • Indian Clinical Trial and Education Network (In-TENT): An initiative to build a network of Research Institutes with a goal of providing evidence based, robust and culturally sensitive solutions to urgent health problems, in a reasonable time frame, by conducting large multi-centric clinical trials.
  • Clinical trial network for hospital-based trials in Oncology (Led by JIPMER)
  • Health technology assessment hub funded by DHR
  • Establishment of network of laboratories for management of epidemics and national calamities
  • Establishment of DHR-ICMR advanced molecular oncology diagnostic services (DIAMONDS)
  • Regional Prospective Observational Research for Tuberculosis (RePORT India Phase II – Common Protocol) and other Indo-US collaborative TB projects
  • Hospital based cancer registry and patterns of care survival studies.
  • Several multicentric trials ongoing in the departments of Medical Oncology, clinical trials in Neurology and Clinical pharmacology.
  • Multi-institutional network program on systemic lupus erythematousus understanding the diversity of SLE